Unknown

Dataset Information

0

Fosfomycin, Applying Known Methods and Remedies to A New Era.


ABSTRACT: The exponential increase in the numbers of isolates of Carbapenem-Resistant Enterobacteriaceae (CRE) creates the need for using novel therapeutic approaches to save the lives of patients. Fosfomycin has long been considered a rational option for the treatment of CRE to be used as part of a combined therapy scheme. However, the assessment of fosfomycin susceptibility in the laboratory presents a great challenge due to the discrepancies found between different methodologies. Thus, our goal was to evaluate fosfomycin susceptibility in a group of 150 Enterobacteriaceae bacterial isolates using agar dilution as the gold standard technique to compare the results with those obtained by disk diffusion. We found a fosfomycin susceptibility of 79.3% in general terms. By comparing both methodologies, we reported a categorical agreement of 96% without Very Major Errors (VMEs) or Major Errors (MEs) and 4% of minor Errors (mEs). Our results suggest that fosfomycin could provide a rational alternative treatment for those patients that are infected by a Multidrug-Resistant (MDR) microorganism that is currently untreatable and that the disk diffusion and classical agar dilution techniques are adequate to assess the resistance profile of CRE to fosfomycin.

SUBMITTER: M VA 

PROVIDER: S-EPMC7564589 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fosfomycin, Applying Known Methods and Remedies to A New Era.

M Viviana Albán VA   Mariño-Brito Estefanía E   Villavicencio Fernando F   Satán Carolina C   Villacís José E JE   Gestal Mónica C MC  

Diseases (Basel, Switzerland) 20200807 3


The exponential increase in the numbers of isolates of Carbapenem-Resistant <i>Enterobacteriaceae</i> (CRE) creates the need for using novel therapeutic approaches to save the lives of patients. Fosfomycin has long been considered a rational option for the treatment of CRE to be used as part of a combined therapy scheme. However, the assessment of fosfomycin susceptibility in the laboratory presents a great challenge due to the discrepancies found between different methodologies. Thus, our goal  ...[more]

Similar Datasets

| S-EPMC4649162 | biostudies-literature
| S-EPMC1633759 | biostudies-literature
| S-EPMC7437476 | biostudies-literature
| S-EPMC6829121 | biostudies-other
| S-EPMC7182206 | biostudies-literature
| S-EPMC4786888 | biostudies-literature
| S-EPMC8245474 | biostudies-literature
| S-EPMC10458896 | biostudies-literature
| S-EPMC7331002 | biostudies-literature
| S-EPMC4746076 | biostudies-literature